Localization of β-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls

Experimental Neurology

Volumn 175, Issue 1, 2002, Pages 10-22

  Sun, Anyang ^a   Koelsch, Gerald ^b   Tang, Jordan ^b   Bing, Guoying ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Memapsin 2; Neurofibrillary tangles; Senile plaques; amyloid; secretase

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE;

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE;

EID: 0036245342     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2002.7875     Document Type: Article

References (52)

1. Expression patterns of β-amyloid precursor protein (β-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects
2. The spatial patterns of β/A4 deposit subtypes in Alzheimer's disease
3. Expression analysis of BACE2 in brain and peripheral tissues
4. A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's β-secretase
5. Expression of β-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology
6. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease
7. BACE1 is the major β-secretase for generation of Aβ peptides by neurons
8. Generation of amyloid β protein from its precursor is sequence specific
9. Processing of β-secretase by furin and other members of the proprotein convertase family
10. A very incomplete comprehensive theory of Alzheimer's disease
11. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
12. Intraneuronal Aβ42 accumulation in human brain
13. Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme: The Alzheimer's disease β-secretase
14. Identification of a novel aspartic protease (Asp 2) as β-secretase
15. ASP1 (BACE2) cleaves the amyloid precursor protein at the β- secretase site
16. β-site APP cleaving enzyme mRNA expression in APP transgenic mice: Anatomical overlap with transgene expression and static levels with aging
17. Metabolic regulation of brain Aβ by neprilysin
18. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies
19. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment
20. Comparative analysis of amyloid-beta chemical structure and amyloid plaque morphology of transgenic mouse and Alzheimer's disease brains
21. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation
22. Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein
23. Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease
24. Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
25. Amyloid β protein (Aβ) deposition in chromosome 14-1inked Alzheimer's disease: Predominance of Aβ42(43)
26. Distribution and fluidizing action of soluble and aggregated amyloid β-peptide in rat synaptic plasma membranes
27. Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
28. Making the diagnosis of Alzheimer's disease: A primer for practicing pathologists
29. Life and death of neurons in the aging brain
30. Regulation of APP cleavage by α-, β- and γ-secretases
31. The role of presenilin-1 in the γ-secretase cleavage of the amyloid precursor protein of Alzheimer's disease
32. Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein
33. Mutant genes in familial Alzheimer's disease and transgenic models
34. Presenilins, Alzheimer's disease, and capacitative calcium entry
35. "Preclinical" AD revisited: Neuropathology of cognitively normal older adults
36. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein
37. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide
38. Purification and cloning of amyloid precursor protein β-secretase from human brain
39. Detection of a novel intraneuronal pool of insoluble amyloid β protein that accumulates with time in culture
40. Metabolites of the β-amyloid precursor protein generated by β-secretase localise to the trans-Golgi network and late endosome in 293 cells
41. A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease
42. Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex
43. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease
44. Deposition of monomeric, not oligomeric, Aβ mediates growth of Alzheimer's disease amyloid plaques in human brain preparations
45. Morphological features of the entorhinal-hippocampal connection
46. β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE
47. The levels of soluble versus insoluble brain Aβ distinguish Alzheimer's disease from normal and pathologic aging
48. Conformational change as one of the earliest alterations of tau in Alzheimer's disease
49. Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42
50. Lack of specific association of presenilin 1 protein with plaques and tangles in Alzheimer's disease
51. Role of presenilin in γ-secretase cleavage of amyloid precursor protein
52. Membrane-anchored aspartyl protease with Alzheimer's disease β-activity